American College of Cardiology

How a doctor presents themselves on social media can determine how effective it is in getting their message across while also maintaining a safe barrier between them and their patients.

Social media platforms like Facebook and Twitter may be regularly used by patients but some doctors have been slower to incorporate these tools into their practice.

As Xarelto is used in practice by more doctors researchers at Janssen Pharmaceuticals are getting a better sense of its efficacy beyond the extensive clinical trials it underwent.

As one of the components of the CHADS2 score diabetes is a known risk for stroke. A recent study looked at how rivaroxaban, also known as Xarelto can help patients reduce this potentially deadly health issue.

An electronic device that stimulates the vagus nerve improved patients’ ability to walk farther without getting winded and was proven to be safe, but it did not affect rates of death or hospitalization, researchers found.

Stem cell treatment did 37% better than placebo treatment in a group of patients with ischemic heart failure.

Adding aliskiren to enalapril in treating heart failure patients resulted in more adverse events but no benefit, a UK team reported.

For those how enter the field of genetic testing there are many challenges along the way, starting with finding the right training program through using that training in very difficult situations.

As more is learned about genetic conditions in cardiology more is being done to help not only to help the patients themselves but those around them as well.

Hopes that losmapimod would benefit patients after a STEMI heart attack were not borne out by a study reported today at the American College of Cardiology's meeting in Chicago, IL.

The search for a drug to prevent kidney injuries from contrast media used in coronary angiography goes on. Trials of a new drug were disappointing.

Treating atrial fibrillation by ablation is equally effective whether done by freezing or burning small parts of the heart.

In the real world, which patients get P2Y inhibitors? A Mount Sinai team investigated.

A newer version of a valve system used in transcatheter aortic valve replacement has proved superior to surgery in elderly patients. The study was released a day after a report on the older device showed it was as good as surgery.

A large genetic analysis showed that the incidence of a single genetic mutation in familial hypercholesterolemia patients is smaller than thought--but that those who do have the mutation face a far higher risk of heart disease.

Reportingg on a trial known as ACCELERATE, researchers said a powerful CETP inhibitor did not reduce cardiovascular events, despite having “Profound HDL-C raising and LDL-C lowering propertie

There were hundreds of presentations on high-tech innovations and the latest drugs for heart disease. But unless cardiologists find better ways to prevent cardiovascular illness, deaths will keep rising, the ACC's Kim Williams, MD said in his welcome speech.

When patients are statin-intolerant but have high cholesterol, physicians have other options, a Cleveland Clinic study finds.

An Italian team looked at using novel oral anticoagulants (NOAC) as an alternative to warfarin. The NOAC drugs are safer, they reported.

Population health—the quest to improve the physical well-being of people around the world—is increasingly focused on prevention. But giving antihypertensives plus statins to people who do not have high blood pressure has risks.

Trans Aortic Valve Replacement, a less invasive procedure than open heart surgery, offers about the same benefits but slightly different risks, researchers reported today.

Stress directly impacts the arteries. Imaging studies enable physicians to actually see the proof, a Boston, MA team reports.

Despite demographic shifts that are steadily increasing how long people are living,most medical research lumps everyone over 65 (or even over 60) into the same group. That's about to change, say's NYU's John A. Dodson, MD, MPH.

In findings that shocked the Cleveland Clinic researchers who compiled them, heart attack patients are getting younger and have more comorbidities than expected.

Peripartum cardiomyopathy, a dangerous heart condition that can present in the last month of pregnancy, can lead to major cardiac events. Researchers have found a way to evaluate risk using a biomarker, galectin-3.

Conduction abnormalities in patients who undergo transcatheter aortic valve replacement and then need a pacemaker can be worrisome. A Pittsburghm PA team looked at how these patients fared.

In systolic heart failure, a fixed dose combinatin of isosorbide dinitrate and hydralazine is more effective in black patients. Building on that information, researchers in Pittsburgh looked at ways to use a genomic score to predict which patients would benefit most.

Blood lactate levels can predict short-term prognosis in patients who have had primary percutaneous coronary interventions after an acute myocardial infarction

Despite corrective surgery known as the Fontan procedure, children who need that procedure have ongoing deficits.

Swedish researchers have developed a way to predict major bleeding in revascularized patients who have acute coronary syndrome.